Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...

Gilead Sciences’ already dominant position in HIV pre-exposure prophylaxis (PrEP) has been consolidated by a new study showing that its twice-yearly injectable drug was 100% effective in ...

This stunning residence, crafted by COMPLETE by McDONALD JONES HOMES and located in the sought-after Figtree Hill Estate, offers the perfect blend of style and functionality. Featuring four ...